Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Sykem1/Cya
Common Name:
Syk-KO
Product ID:
S-KO-17981
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Syk-KO
Strain ID
KOCMP-20963-Syk-B6J-VA
Gene Name
Syk
Product ID
S-KO-17981
Gene Alias
Sykb
Background
C57BL/6JCya
NCBI ID
20963
Modification
Conventional knockout
Chromosome
13
Phenotype
MGI:99515
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Sykem1/Cya mice (Catalog S-KO-17981) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000120135
NCBI RefSeq
NM_001198977
Target Region
Exon 3
Size of Effective Region
~1.8 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Syk, short for spleen tyrosine kinase, is a non-receptor tyrosine kinase. It is highly expressed in hematopoietic cells and plays crucial roles in diverse biological functions. It is a key player in adaptive immune receptor signalling, and also mediates processes like cellular adhesion, innate immune recognition, osteoclast maturation, platelet activation, and vascular development. It is activated by C-type lectins and integrins, and activates pathways such as the CARD9-BCL-10-MALT1 pathway and the NLRP3 inflammasome [1].

Syk has been implicated in numerous diseases. In autoimmune diseases like immune thrombocytopenia (ITP), rheumatoid arthritis, and systemic lupus erythematosus, Syk-signaling pathway is a potential target for treatment. Fostamatinib, a Syk inhibitor, has shown clinical response in ITP patients, including those refractory to other treatments [2,7]. In hematological malignancies, Syk is recognized as a critical element in the B-cell receptor signaling pathway, and several oral Syk inhibitors are being assessed in clinical trials [3]. In solid tumors, it shows a paradoxical role, acting as a tumor suppressor in some cancers while driving tumor growth in others [4]. In cardio-cerebrovascular diseases such as atherosclerosis, heart failure, and diabetic cardiomyopathy, Syk is involved in their progression [5]. Also, in Helicobacter pylori-induced gastric mucosal inflammatory responses, Syk activation leads to up-regulation of proinflammatory genes [6].

In conclusion, Syk is essential for multiple biological functions from immune responses to cell-cell interactions. The study of Syk using various models, potentially including KO/CKO mouse models (although not explicitly detailed in the given references about these models), has significantly contributed to understanding its role in diseases like autoimmune disorders, hematological malignancies, solid tumors, cardio-cerebrovascular diseases, and gastric inflammatory responses. This knowledge provides a basis for developing therapeutic strategies targeting Syk.

References:
1. Mócsai, Attila, Ruland, Jürgen, Tybulewicz, Victor L J. . The SYK tyrosine kinase: a crucial player in diverse biological functions. In Nature reviews. Immunology, 10, 387-402. doi:10.1038/nri2765. https://pubmed.ncbi.nlm.nih.gov/20467426/
2. Cooper, Nichola, Ghanima, Waleed, Hill, Quentin A, Markovtsov, Vadim, Kessler, Craig. 2022. Recent advances in understanding spleen tyrosine kinase (SYK) in human biology and disease, with a focus on fostamatinib. In Platelets, 34, 2131751. doi:10.1080/09537104.2022.2131751. https://pubmed.ncbi.nlm.nih.gov/36331249/
3. Liu, Delong, Mamorska-Dyga, Aleksandra. 2017. Syk inhibitors in clinical development for hematological malignancies. In Journal of hematology & oncology, 10, 145. doi:10.1186/s13045-017-0512-1. https://pubmed.ncbi.nlm.nih.gov/28754125/
4. Joshi, Shweta. 2024. New insights into SYK targeting in solid tumors. In Trends in pharmacological sciences, 45, 904-918. doi:10.1016/j.tips.2024.08.006. https://pubmed.ncbi.nlm.nih.gov/39322438/
5. Li, Mohan, Wang, Pengbo, Zou, Yuanming, Zhang, Naijin, Sun, Yingxian. 2023. Spleen tyrosine kinase (SYK) signals are implicated in cardio-cerebrovascular diseases. In Heliyon, 9, e15625. doi:10.1016/j.heliyon.2023.e15625. https://pubmed.ncbi.nlm.nih.gov/37180910/
6. Slomiany, Bronislaw L, Slomiany, Amalia. 2019. Syk: a new target for attenuation of Helicobacter pylori-induced gastric mucosal inflammatory responses. In Inflammopharmacology, 27, 203-211. doi:10.1007/s10787-019-00577-6. https://pubmed.ncbi.nlm.nih.gov/30820719/
7. Deng, Guo-Min, Kyttaris, Vasileios C, Tsokos, George C. 2016. Targeting Syk in Autoimmune Rheumatic Diseases. In Frontiers in immunology, 7, 78. doi:10.3389/fimmu.2016.00078. https://pubmed.ncbi.nlm.nih.gov/27014261/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest